Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Status:
Terminated
Trial end date:
1998-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for children with recurrent/progressive high grade gliomas
provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston
therapy suggest that it may prove beneficial in the treatment of children with
recurrent/progressive high grade gliomas.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on children (> 6 months of age) with recurrent/progressive high
grade gliomas.